Novartis Escapes Some Lotensin Claims

Law360, New York (March 25, 2008, 12:00 AM EDT) -- A federal district judge has tossed some of the claims brought against Novartis Pharmaceuticals Corp. by a woman who alleges that her infant son died due to complications from the popular hypertension drug Lotensin, which she took during the first trimester of her pregnancy.

On Tuesday, U.S. District Judge Martin Reidinger partially granted Novartis' motion to dismiss, ruling that the failure to warn and inadequate labeling charges were preempted by the Food and Drug Administration labeling process.

The origins of the suit date back several years,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.